<DOC>
	<DOCNO>NCT02658552</DOCNO>
	<brief_summary>To evaluate short-term efficacy high intensity focus ultrasound ( HIFU ) treatment benign thyroid nodule</brief_summary>
	<brief_title>A Prospective Evaluation High Intensity Focused Ultrasound ( HIFU ) Treatment Benign Thyroid Nodules</brief_title>
	<detailed_description>Background : Thyroid nodule common worldwide . In iodine-replete population like Hong Kong , estimate prevalence clinically palpable thyroid nodule , close 5 % prevalence ultrasonically detectable nodule could 67 % . With frequent use compute tomography , carotid ultrasound study positron emission scan nowadays , many small , non-palpable thyroid nodule incidentally detect . The use high intensity focus ultrasound MRI guide ultrasound guide used treat different type soft tissue cancer like prostate cancer , liver cancer breast cancer . This device try clinical study patient thyroid nodule , already schedule thyroidectomy , treat use HIFU order evaluate safety feasibility device well determine treatment parameter effect . The result show overall safety treatment satisfactory lesion produce HIFU shot nodule precise . This pilot study extend clinical trial patient benign thyroid nodule treat . Twenty-one patient treat study versus 11 control . No serious adverse event ( SAE ) occur . A patient toxic thyroid nodule also treat HIFU device ( Theraclion , France ) . The treatment well tolerate biologic euthyroidism achieve 3 month ( TSH , 1.91 mIU/L ) maintain 6 , 12 , 18 month . At 12 18 month , treat nodule barely see nonvascularized hypoechoic scar . Thyroid scintigraphy show recovery thyroid iodine uptake . Since November 1st 2007 , HIFU device ( Theraclion , France ) CE mark HIFU treatment neck pathology . 11 patient primary hyperparathyroidism treat follow . The mean follow-up 9.5 month ( 1-28 month ) . Symptomatic hypocalcaemia observe patient HIFU treatment follow-up . A prospective monocenter study perform Bulgaria treatment benign solid thyroid nodule US-Guided HIFU . Twenty thyroid nodule treat one HIFU session . The mean ± standard deviation nodule volume 4.96 mL ± 2.79 start study . Nodule volume decrease 3.05 mL ±1.96 3-month follow-up examination ( n = 20 , P &lt; .001 ) , reach 2.91 mL ± 2.43 6-month follow-up examination ( n = 16 , P &lt; .001 ) . By , mean volume reduction 48.7 % ± 24.3 ( P &lt; .001 ) . Minor transient complication subcutaneous edema mild skin redness observe two patient . Another monocenter study perform Germany 2014 . Ten patient one thyroid nodule treat HIFU . Three month procedure , thyroid nodule volume significantly reduce 48.8 % ( median ) shrinkage 75 % volume observe . In term safety , serious side effect relate procedure report . Objectives : The present study aim explore following : 1 . To evaluate efficacy HIFU treatment benign thyroid nodule use assessment patient experience adverse event reporting . 2 . To evaluate tolerance HIFU treatment benign thyroid nodule . 3 . To determine location parameter associate optimal efficiency tissue ablation . The procedure schedule comprises : - An first visit ( V0 ) - The HIFU session ( D0 ) - A visit 1 , 3 7 day HIFU session ( D1 , D3 , D7 ) - A visit 3 6 month ( M3 , M6 ) . - At visit : local and/or general adverse event document case report form ( CRF ) . Ultrasound measurement treat nodule ( 3 dimension ) perform schedule visit . The treatment procedure Echopulse consist five treatment step : - Pre-treatment ultrasonography - Positioning - Planning - Generation HIFU treatment pulse volume define ; power set achieve regularly space site subset . - Post-treatment visualization final report . The parameter HIFU treatment part clinical study data base . When HIFU session prematurely interrupt , reason interruption record CRF ( adverse event , technical failure , others ) . Study duration lbe 6 month patient , count post-HIFU day .</detailed_description>
	<mesh_term>Thyroid Diseases</mesh_term>
	<mesh_term>Thyroid Nodule</mesh_term>
	<criteria>Male female patient 18 year old . Patient present least one thyroid nodule sign malignancy : 1 . Non suspicious clinically ultrasonography image 2 . Benign cytological diagnosis fine needle aspiration biopsy last 6 month 3 . Normal serum calcitonin 4 . No history neck irradiation Serum TSH free T4 level within normal range Targeted nodule deem accessible eligible HIFU Absence vocal cord paresis laryngoscopy Nodule great diameter ≥10 20mm measure ultrasound Composition target nodule ( ) : predominantly solid Patient mentally competent give informed consent . Head and/or neck disease prevent extension neck Known history thyroid cancer malignant tumor neck region History neck irradiation Intranodular macrocalcification induce shadow thyroid significant enough preclude HIFU treatment A nodule next posterior margin lobe distance &lt; 15mm Pregnant lactate woman Any contraindication assign analgesia/anaesthesia .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>HIFU</keyword>
	<keyword>Benign thyroid nodule</keyword>
	<keyword>Low risk</keyword>
	<keyword>New treatment</keyword>
</DOC>